Answer
Women of childbearing potential must use effective contraception throughout filgotinib maleate treatment and for at least one week after stopping treatment.
Sources for this answer
- Jyseleca 100 mg film-coated tabletsAlfasigma UK Limited (formerly Galapagos Biotech Limited) · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 20Document updated
Sources checked